Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

June 01, 2007; Volume 321,Issue 3

PERSPECTIVES IN PHARMACOLOGY

  • You have access
    Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses
    Hyoung-gon Lee, Xiongwei Zhu, Rudy J. Castellani, Akihiko Nunomura, George Perry and Mark A. Smith
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 823-829; DOI: https://doi.org/10.1124/jpet.106.114009

BEHAVIORAL PHARMACOLOGY

  • You have access
    The Reinforcing Actions of a Serotonin-3 Receptor Agonist within the Ventral Tegmental Area: Evidence for Subregional and Genetic Differences and Involvement of Dopamine Neurons
    Zachary A. Rodd, Victoria E. Gryszowka, Jamie E. Toalston, Scott M. Oster, Dong Ji, Richard L. Bell and William J. McBride
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1003-1012; DOI: https://doi.org/10.1124/jpet.106.112607
  • You have access
    Nicotinic Facilitation of Δ9-Tetrahydrocannabinol Discrimination Involves Endogenous Anandamide
    Marcello Solinas, Maria Scherma, Gianluigi Tanda, Carrie E. Wertheim, Walter Fratta and Steven R. Goldberg
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1127-1134; DOI: https://doi.org/10.1124/jpet.106.116830
  • You have access
    Modulation of Heroin and Cocaine Self-Administration by Dopamine D1- and D2-Like Receptor Agonists in Rhesus Monkeys
    James K. Rowlett, Donna M. Platt, Wei-Dong Yao and Roger D. Spealman
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1135-1143; DOI: https://doi.org/10.1124/jpet.107.120766

CARDIOVASCULAR

  • You have access
    Identification of IKr and Its Trafficking Disruption Induced by Probucol in Cultured Neonatal Rat Cardiomyocytes
    Jun Guo, Hamid Massaeli, Wentao Li, Jianmin Xu, Tao Luo, James Shaw, Lorrie A. Kirshenbaum and Shetuan Zhang
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 911-920; DOI: https://doi.org/10.1124/jpet.107.120931
  • You have access
    Effects of Phloretin and Phloridzin on Ca2+ Handling, the Action Potential, and Ion Currents in Rat Ventricular Myocytes
    Marnie L. Olson, Margaret E. Kargacin, Christopher A. Ward and Gary J. Kargacin
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 921-929; DOI: https://doi.org/10.1124/jpet.107.121111
  • You have access
    Delivery of Anti-Platelet-Endothelial Cell Adhesion Molecule Single-Chain Variable Fragment-Urokinase Fusion Protein to the Cerebral Vasculature Lyses Arterial Clots and Attenuates Postischemic Brain Edema
    Kristina Danielyan, Bi-Sen Ding, Claudia Gottstein, Douglas B. Cines and Vladimir R. Muzykantov
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 947-952; DOI: https://doi.org/10.1124/jpet.107.120535
  • You have access
    Pharmacological Activation of Rapid Delayed Rectifier Potassium Current Suppresses Bradycardia-Induced Triggered Activity in the Isolated Guinea Pig Heart
    Rie Schultz Hansen, Søren-Peter Olesen and Morten Grunnet
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 996-1002; DOI: https://doi.org/10.1124/jpet.106.118448
  • You have access
    Characterization of 14,15-Epoxyeicosatrienoyl-Sulfonamides as 14,15-Epoxyeicosatrienoic Acid Agonists: Use for Studies of Metabolism and Ligand Binding
    Wenqi Yang, Blythe B. Holmes, V. Raj Gopal, R. V. Krishna Kishore, Bhavani Sangras, Xiu-Yu Yi, J. R. Falck and William B. Campbell
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1023-1031; DOI: https://doi.org/10.1124/jpet.107.119651
  • You have access
    Stimulation of Ca2+-Gated Cl- Currents by the Calcium-Dependent K+ Channel Modulators NS1619 [1,3-Dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one] and Isopimaric Acid
    Sohag N. Saleh, Jeff E. Angermann, William R. Sones, Normand Leblanc and Iain A. Greenwood
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1075-1084; DOI: https://doi.org/10.1124/jpet.106.118786

CELLULAR AND MOLECULAR

  • You have access
    Rapid Modulation of μ-Opioid Receptor Signaling in Primary Sensory Neurons
    Kelly A. Berg, Amol M. Patwardhan, Teresa A. Sanchez, Yamille M. Silva, Kenneth M. Hargreaves and William P. Clarke
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 839-847; DOI: https://doi.org/10.1124/jpet.106.116681
  • You have access
    A Role for Akt in Epidermal Growth Factor-Stimulated Cell Cycle Progression in Cultured Hepatocytes: Generation of a Hyperproliferative Window after Adenoviral Expression of Constitutively Active Akt
    Yi Luo, C. Jane Dixon, John F. Hall, Pamela J. White and Michael R. Boarder
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 884-891; DOI: https://doi.org/10.1124/jpet.107.121061
  • You have access
    Histone Deacetylase Inhibitors Exhibit Anti-Inflammatory and Neuroprotective Effects in a Rat Permanent Ischemic Model of Stroke: Multiple Mechanisms of Action
    Hyeon Ju Kim, Michael Rowe, Ming Ren, Jau-Shyong Hong, Po-See Chen and De-Maw Chuang
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 892-901; DOI: https://doi.org/10.1124/jpet.107.120188
  • You have access
    Anandamide-Mediated CB1/CB2 Cannabinoid Receptor-Independent Nitric Oxide Production in Rabbit Aortic Endothelial Cells
    LaTronya McCollum, Allyn C. Howlett and Somnath Mukhopadhyay
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 930-937; DOI: https://doi.org/10.1124/jpet.106.117549
  • You have access
    Targeting AML1/ETO-Histone Deacetylase Repressor Complex: A Novel Mechanism for Valproic Acid-Mediated Gene Expression and Cellular Differentiation in AML1/ETO-Positive Acute Myeloid Leukemia Cells
    Shujun Liu, Rebecca B. Klisovic, Tamara Vukosavljevic, Jianhua Yu, Peter Paschka, Lenguyen Huynh, Jiuxia Pang, Paolo Neviani, Zhongfa Liu, William Blum, Kenneth K. Chan, Danilo Perrotti and Guido Marcucci
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 953-960; DOI: https://doi.org/10.1124/jpet.106.118406
  • You have access
    Mutations of Cys-17 and Ala-271 in the Human Histamine H2 Receptor Determine the Species Selectivity of Guanidine-Type Agonists and Increase Constitutive Activity
    Hendrik Preuss, Prasanta Ghorai, Anja Kraus, Stefan Dove, Armin Buschauer and Roland Seifert
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 975-982; DOI: https://doi.org/10.1124/jpet.107.120519
  • You have access
    Constitutive Activity and Ligand Selectivity of Human, Guinea Pig, Rat, and Canine Histamine H2 Receptors
    Hendrik Preuss, Prasanta Ghorai, Anja Kraus, Stefan Dove, Armin Buschauer and Roland Seifert
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 983-995; DOI: https://doi.org/10.1124/jpet.107.120014
  • You have access
    Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors
    Pablo R. Moya, Kelly A. Berg, Manuel A. Gutiérrez-Hernandez, Patricio Sáez-Briones, Miguel Reyes-Parada, Bruce K. Cassels and William P. Clarke
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1054-1061; DOI: https://doi.org/10.1124/jpet.106.117507
  • You have access
    In Vitro and in Vivo Pharmacological Characterization of Ethyl-4-{trans-4-[((2S)-2-hydroxy-3-{4-hydroxy-3[(methylsulfonyl)amino]-phenoxy}propyl) Amino]cyclohexyl}benzoate Hydrochloride (SAR150640), a New Potent and Selective Human β3-Adrenoceptor Agonist for the Treatment of Preterm Labor
    Tiziano Croci, Roberto Cecchi, Pietro Marini, Céline Rouget, Nunzia Viviani, Guy Germain, Fabio Guagnini, Yvon Fradin, Laurence Descamps, Marc Pascal, Charles Advenier, Michelle Breuiller-Fouché, Marie-Josèphe Leroy and Marc Bardou
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1118-1126; DOI: https://doi.org/10.1124/jpet.106.119123
  • You have access
    Estimation of Agonist Activity at G Protein-Coupled Receptors: Analysis of M2 Muscarinic Receptor Signaling through Gi/o,Gs, and G15
    Michael T. Griffin, Katherine W. Figueroa, Sarah Liller and Frederick J. Ehlert
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1193-1207; DOI: https://doi.org/10.1124/jpet.107.120857

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

  • You have access
    Chlorambucil Cytotoxicity in Malignant B Lymphocytes Is Synergistically Increased by 2-(Morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-Mediated Inhibition of DNA Double-Strand Break Repair via Inhibition of DNA-Dependent Protein Kinase
    Lilian Amrein, Martin Loignon, Anne-Christine Goulet, Michael Dunn, Bertrand Jean-Claude, Raquel Aloyz and Lawrence Panasci
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 848-855; DOI: https://doi.org/10.1124/jpet.106.118356
  • You have access
    Ethonafide-Induced Cytotoxicity Is Mediated by Topoisomerase II Inhibition in Prostate Cancer Cells
    Alan Pourpak, Terry H. Landowski and Robert T. Dorr
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1109-1117; DOI: https://doi.org/10.1124/jpet.106.117457

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

  • You have access
    Local Inhibition of Liver Fibrosis by Specific Delivery of a Platelet-Derived Growth Factor Kinase Inhibitor to Hepatic Stellate Cells
    Teresa Gonzalo, Leonie Beljaars, Marja van de Bovenkamp, Kai Temming, Anne-Miek van Loenen, Catharina Reker-Smit, Dirk K. F. Meijer, Marie Lacombe, Frank Opdam, György Kéri, László Örfi, Klaas Poelstra and Robbert J. Kok
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 856-865; DOI: https://doi.org/10.1124/jpet.106.114496
  • You have access
    Soraprazan: Setting New Standards in Inhibition of Gastric Acid Secretion
    W. A. Simon, M. Herrmann, T. Klein, J. M. Shin, R. Huber, J. Senn-Bilfinger and S. Postius
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 866-874; DOI: https://doi.org/10.1124/jpet.107.120428
  • You have access
    Protein Kinase A Inhibits Lysophosphatidic Acid-Induced Migration of Airway Smooth Muscle Cells
    Masakazu Hirakawa, Yuji Karashima, Michi Watanabe, Chiwaka Kimura, Yushi Ito and Masahiro Oike
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1102-1108; DOI: https://doi.org/10.1124/jpet.106.118042

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

  • You have access
    ATP-Depleting Carbohydrates Prevent Tumor Necrosis Factor Receptor 1-Dependent Apoptotic and Necrotic Liver Injury in Mice
    Markus Latta, Gerald Künstle, Rudolf Lucas, Hannes Hentze and Albrecht Wendel
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 875-883; DOI: https://doi.org/10.1124/jpet.107.119958
  • You have access
    Inhaled CD86 Antisense Oligonucleotide Suppresses Pulmonary Inflammation and Airway Hyper-Responsiveness in Allergic Mice
    Jeffrey R. Crosby, Mausumee Guha, David Tung, Doreen A. Miller, Brianna Bender, Thomas P. Condon, Cathie York-DeFalco, Richard S. Geary, Brett P. Monia, James G. Karras and Susan A. Gregory
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 938-946; DOI: https://doi.org/10.1124/jpet.106.119214
  • You have access
    Anti-Inflammatory Activity of a Potent, Selective Leukotriene A4 Hydrolase Inhibitor in Comparison with the 5-Lipoxygenase Inhibitor Zileuton
    Navin L. Rao, Paul J. Dunford, Xiaohua Xue, Xiaohui Jiang, Katherine A. Lundeen, Fawn Coles, Jason P. Riley, Kacy N. Williams, Cheryl A. Grice, James P. Edwards, Lars Karlsson and Anne M. Fourie
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1154-1160; DOI: https://doi.org/10.1124/jpet.106.115436

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

  • You have access
    Cholesterol Potentiates ABCG2 Activity in a Heterologous Expression System: Improved in Vitro Model to Study Function of Human ABCG2
    Á. Pál, D. Méhn, É. Molnár, S. Gedey, P. Mészáros, T. Nagy, H. Glavinas, T. Janáky, O. von Richter, G. Báthori, L. Szente and P. Krajcsi
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1085-1094; DOI: https://doi.org/10.1124/jpet.106.119289
  • You have access
    Differential Inhibition of Rat and Human Na+-Dependent Taurocholate Cotransporting Polypeptide (NTCP/SLC10A1)by Bosentan: A Mechanism for Species Differences in Hepatotoxicity
    Elaine M. Leslie, Paul B. Watkins, Richard B. Kim and Kim L. R. Brouwer
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1170-1178; DOI: https://doi.org/10.1124/jpet.106.119073

NEUROPHARMACOLOGY

  • You have access
    l-3-n-Butylphthalide Improves Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats
    Ying Peng, Shaofeng Xu, Guiquan Chen, Ling Wang, Yipu Feng and Xiaoliang Wang
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 902-910; DOI: https://doi.org/10.1124/jpet.106.118760
  • You have access
    Pharmacological Characterization of the Nociceptin/Orphanin FQ Receptor Antagonist SB-612111 [(–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In Vitro Studies
    Barbara Spagnolo, Giacomo Carrà, Martina Fantin, Carmela Fischetti, Chris Hebbes, John McDonald, Timothy A. Barnes, Anna Rizzi, Claudio Trapella, Giulia Fanton, Michele Morari, Dave G. Lambert, Domenico Regoli and Girolamo Calò
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 961-967; DOI: https://doi.org/10.1124/jpet.106.116764
  • You have access
    Pharmacological Characterization of the Nociceptin/Orphanin FQ Receptor Antagonist SB-612111 [(–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In Vivo Studies
    Anna Rizzi, Elaine C. Gavioli, Giuliano Marzola, Barbara Spagnolo, Silvia Zucchini, Roberto Ciccocioppo, Claudio Trapella, Domenico Regoli and Girolamo Calò
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 968-974; DOI: https://doi.org/10.1124/jpet.106.116780
  • You have access
    Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents
    Tung M. Fong, Xiao-Ming Guan, Donald J. Marsh, Chun-Pyn Shen, D. Sloan Stribling, Kim M. Rosko, Julie Lao, Hong Yu, Yue Feng, Jing C. Xiao, Lex H. T. Van der Ploeg, Mark T. Goulet, Williams K. Hagmann, Linus S. Lin, Thomas J. Lanza, James P. Jewell, Ping Liu, Shrenik K. Shah, Hongbo Qi, Xinchun Tong, Junying Wang, Suoyu S. Xu, Barbara Francis, Alison M. Strack, D. Euan MacIntyre and Lauren P. Shearman
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1013-1022; DOI: https://doi.org/10.1124/jpet.106.118737
  • You have access
    GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer's Disease Brain and Improves Cognitive Performance in Preclinical Models
    Andrew D. Medhurst, Alan R. Atkins, Isabel J. Beresford, Kim Brackenborough, Michael A. Briggs, Andrew R. Calver, Jackie Cilia, Jane E. Cluderay, Barry Crook, John B. Davis, Rebecca K. Davis, Robert P. Davis, Lee A. Dawson, Andrew G. Foley, Jane Gartlon, M. Isabel Gonzalez, Teresa Heslop, Warren D. Hirst, Carol Jennings, Declan N. C. Jones, Laurent P. Lacroix, Abbe Martyn, Sandrine Ociepka, Alison Ray, Ciaran M. Regan, Jennifer C. Roberts, Joanne Schogger, Eric Southam, Tania O. Stean, Brenda K. Trail, Neil Upton, Graham Wadsworth, Jeffrey A. Wald, Trevor White, Jason Witherington, Marie L. Woolley, Angela Worby and David M. Wilson
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1032-1045; DOI: https://doi.org/10.1124/jpet.107.120311
  • You have access
    Roles of 5-Hydroxytryptamine (5-HT) Receptor Subtypes in the Inhibitory Effects of 5-HT on C-Fiber Responses of Spinal Wide Dynamic Range Neurons in Rats
    Feng-Yu Liu, Guo-Gang Xing, Xiao-Xiu Qu, Isabella S. Xu, Ji-Sheng Han and You Wan
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1046-1053; DOI: https://doi.org/10.1124/jpet.106.115204
  • You have access
    α1A-Adrenergic Receptors Are Functionally Expressed by a Subpopulation of Cornu Ammonis 1 Interneurons in Rat Hippocampus
    Kristin L. Hillman, Van A. Doze and James E. Porter
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1062-1068; DOI: https://doi.org/10.1124/jpet.106.119297
  • You have access
    Subunit-Dependent Modulation of the 5-Hydroxytryptamine Type 3 Receptor Open-Close Equilibrium by n-Alcohols
    Dirk Rüsch, Boris Musset, Hinnerk Wulf, Anika Schuster and Douglas E. Raines
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1069-1074; DOI: https://doi.org/10.1124/jpet.106.118752
  • You have access
    Pharmacological Characterization of a New, Orally Active and Potent Allosteric Metabotropic Glutamate Receptor 1 Antagonist, 4-[1-(2-Fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC)
    Gentaroh Suzuki, Toshifumi Kimura, Akio Satow, Naoki Kaneko, Junko Fukuda, Hirohiko Hikichi, Naoko Sakai, Shunsuke Maehara, Hiroko Kawagoe-Takaki, Mikiko Hata, Tomoko Azuma, Satoru Ito, Hiroshi Kawamoto and Hisashi Ohta
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1144-1153; DOI: https://doi.org/10.1124/jpet.106.116574
  • You have access
    Genetic Approaches Identify Differential Roles for α4β2* Nicotinic Receptors in Acute Models of Antinociception in Mice
    M. I. Damaj, C. Fonck, M. J. Marks, P. Deshpande, C. Labarca, H. A. Lester, A. C. Collins and B. R. Martin
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1161-1169; DOI: https://doi.org/10.1124/jpet.106.112649
  • You have access
    The Acetylcholinesterase Inhibitor Galantamine Inhibits d-Amphetamine-Induced Psychotic-Like Behavior in Cebus Monkeys
    Maibritt B. Andersen, Thomas Werge and Anders Fink-Jensen
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1179-1182; DOI: https://doi.org/10.1124/jpet.107.119677
  • You have access
    Characterization of SB-705498, a Potent and Selective Vanilloid Receptor-1 (VR1/TRPV1) Antagonist That Inhibits the Capsaicin-, Acid-, and Heat-Mediated Activation of the Receptor
    Martin J. Gunthorpe, Sara Luis Hannan, Darren Smart, Jeffrey C. Jerman, Sandra Arpino, Graham D. Smith, Stephen Brough, Jim Wright, Julie Egerton, Sarah C. Lappin, Vicky A. Holland, Kim Winborn, Mervyn Thompson, Harshad K. Rami, Andrew Randall and John B. Davis
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1183-1192; DOI: https://doi.org/10.1124/jpet.106.116657
  • You have access
    Characterization of the Antinociceptive Actions of Bicifadine in Models of Acute, Persistent, and Chronic Pain
    Anthony S. Basile, Aaron Janowsky, Krystyna Golembiowska, Magdalena Kowalska, Eyal Tam, Morris Benveniste, Piotr Popik, Agnieszka Nikiforuk, Martyna Krawczyk, Gabriel Nowak, Philip A. Krieter, Arnold S. Lippa, Phil Skolnick and Elena Koustova
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1208-1225; DOI: https://doi.org/10.1124/jpet.106.116483

TOXICOLOGY

  • You have access
    Transient Receptor Potential Vanilloid 1 Agonists Cause Endoplasmic Reticulum Stress and Cell Death in Human Lung Cells
    Karen C. Thomas, Ashwini S. Sabnis, Mark E. Johansen, Diane L. Lanza, Philip J. Moos, Garold S. Yost and Christopher A. Reilly
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 830-838; DOI: https://doi.org/10.1124/jpet.107.119412
  • You have access
    S-(1,2,2-Trichlorovinyl)-l-cysteine Sulfoxide, a Reactive Metabolite of S-(1,2,2-Trichlorovinyl)-l-cysteine Formed in Rat Liver and Kidney Microsomes, Is a Potent Nephrotoxicant
    Adnan A. Elfarra and Renee J. Krause
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 1095-1101; DOI: https://doi.org/10.1124/jpet.107.120444
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 321 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 321, Issue 3
1 Jun 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • PERSPECTIVES IN PHARMACOLOGY
  • BEHAVIORAL PHARMACOLOGY
  • CARDIOVASCULAR
  • CELLULAR AND MOLECULAR
  • CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY
  • GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
  • INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA
  • METABOLISM, TRANSPORT, AND PHARMACOGENOMICS
  • NEUROPHARMACOLOGY
  • TOXICOLOGY
  • Most Read
Loading
  • Smoking Could Worsen COVID-19 Outcome
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Potential Clinical Uses of CBG
  • Nose-to-Brain Delivery
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics